[Parenteral nutrition in premature babies with a birth weight <1500g: a systematic single-center analysis and

Melanie Sirch1, Martin Poryo2, Mona Butte1

  • 1Klinik für Allgemeine Pädiatrie und Neonatologie, Universitätsklinikum des Saarlandes, Geb. 9, Kirrberger Str., 66421, Homburg, Deutschland.

Insights

Parenteral nutrition in preterm infants was often inadequate, not meeting German guidelines, leading to poor early growth. Metabolic issues in extremely low birth weight infants complicate guideline adherence, with long-term outcomes still uncertain.

Area of Science:

  • Neonatal intensive care
  • Pediatric nutrition
  • Perinatal medicine

Background:

  • Parenteral and enteral nutrition are crucial for preterm infant growth and development.
  • Debate exists regarding optimal nutritional growth rates and substrate delivery via parenteral nutrition.
  • Very low birth weight (VLBW) and extremely low birth weight (ELBW) infants require specialized nutritional support.

Purpose of the Study:

  • To evaluate parenteral nutrition practices for VLBW and ELBW infants.
  • To compare substrate delivery in a neonatal intensive care unit (NICU) against German guidelines.
  • To assess the impact of parenteral nutrition on early growth and neurodevelopmental outcomes.

Main Methods:

  • Retrospective audit conducted at a tertiary NICU.
  • Data collected from January 2009 to December 2010.
  • Included 100 preterm neonates with birth weights <1500g (VLBW/ELBW).

Main Results:

  • Only glucose provision met German guidelines; other substrates were often inadequate.
  • Hyperglycemia requiring insulin treatment was observed, particularly in ELBW infants.
  • Initial growth faltering in the first 3 weeks was followed by catch-up growth by 2 years corrected age.
  • 78.6% of infants showed normal development at 2 years corrected age (Bayley II test).

Conclusions:

  • Parenteral nutrition in the studied NICU often deviated from German guidelines, correlating with inadequate early growth.
  • Metabolic disturbances, especially in ELBW neonates, hinder guideline implementation.
  • The long-term benefits of guideline adherence on growth and neurodevelopment require further investigation.
Abstract

Related Concept Videos

Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...